New in Mycoses: A pooled Phase 2/3 analysis shows rezafungin was non-inferior to caspofungin for invasive candidiasis and candidaemia, with earlier mycological eradication and a comparable safety profile. Read more: doi.org/10.1111/myc.... #Mycoses #IDTwitter #MedMycology #Antifungals
Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 TrialsBackground The efficacy and safety of rezafungin in invasive candidiasis (IC) and candidaemia was demonstrated in the Phase 2 STRIVE and Phase 3 ReSTORE trials, and an additional cohort of patients ...doi.org